943 results on '"Hasle, Henrik"'
Search Results
2. Selective pressures of platinum compounds shape the evolution of therapy-related myeloid neoplasms
3. Educational attainment in survivors of childhood cancer in Denmark, Finland, and Sweden
4. Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia
5. A novel serum calprotectin (MRP8/14) particle-enhanced immuno-turbidimetric assay (sCAL turbo) helps to differentiate systemic juvenile idiopathic arthritis from other diseases in routine clinical laboratory settings
6. Therapeutic targeting in pediatric acute myeloid leukemia with aberrant HOX/MEIS1 expression
7. HNA specificity and association to HLA-DRB1 and -DQB1 in patients with autoimmune neutropenia of early childhood
8. Survival outcomes of children with relapsed or refractory myeloid leukemia associated with Down syndrome
9. European standard clinical practice – Key issues for the medical care of individuals with familial leukemia
10. Hypodiploidy has unfavorable impact on survival in pediatric acute myeloid leukemia: an I-BFM Study Group collaboration
11. Management of hyperleukocytosis in pediatric acute myeloid leukemia using immediate chemotherapy without leukapheresis: results from the NOPHO-DBH AML 2012 Protocol
12. Upregulation of Insulin-like Growth Factor-I in Response to Chemotherapy in Children with Acute Lymphoblastic Leukemia.
13. Congenital Tooth Agenesis and Risk of Early-Onset Cancer
14. A frameshift variant in specificity protein 1 triggers superactivation of Sp1-mediated transcription in familial bone marrow failure
15. Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes
16. Measurable Residual Disease Monitoring of SPAG6, ST18, PRAME, and XAGE1A Expression in Peripheral Blood May Detect Imminent Relapse in Childhood Acute Myeloid Leukemia
17. The impact of the temporal sequence of cranial radiotherapy and platin-based chemotherapy on hearing impairment in pediatric and adolescent CNS and head-and-neck cancer patients:A report from the PanCareLIFE consortium
18. JMML WITH NRAS MUTATION IN ELANE ASSOCIATED SEVERE CONGENITAL NEUTROPENIA
19. GENOTYPE/PHENOTYPE ASSOCIATIONS IN 174 INDIVIDUALS WITH GERMLINE GATA2 MUTATIONS
20. RELAPSED UBTF-TD MDS TREATED WITH VENETOCLAX AND AZACITIDINE
21. MYELODYSPLASIA-RELATED CYTOGENETIC ABNORMALITES IN CHILDHOOD ACUTE MYELOID LEUKEMIA – A 20-YEAR I-BFM- AML COLLABORATIVE DATABASE STUDY
22. WHAT CAN WE DEDUCE FROM MOLECULAR CLASSIFICATION OF MYELOID NEOPLASIA FOR THERAPY IN PEDIATRICS?
23. Educational attainment in survivors of childhood cancer in Denmark, Finland, and Sweden
24. Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia
25. Study protocol: rehabilitation including social and physical activity and education in children and teenagers with cancer (RESPECT)
26. Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group
27. Risk-adapted treatment of acute promyelocytic leukemia: results from the International Consortium for Childhood APL
28. Publisher Correction: Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes
29. Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia.
30. The effect of a single SMARCA4 exon deletion on RNA splicing: Implications for variant classification
31. Epidemiological Study of Malignant Paediatric Liver Tumours in Denmark 1985–2020
32. Giant cell tumour of bone in os sacrum of a prepubertal girl – Surgical and medical treatment with zoledronate and denosumab
33. Therapy reduction in patients with Down syndrome and myeloid leukemia: the international ML-DS 2006 trial
34. Effects of a physical activity program from diagnosis on cardiorespiratory fitness in children with cancer: a national non-randomized controlled trial
35. P37 - JMML WITH NRAS MUTATION IN ELANE ASSOCIATED SEVERE CONGENITAL NEUTROPENIA
36. P28 - RELAPSED UBTF-TD MDS TREATED WITH VENETOCLAX AND AZACITIDINE
37. P27 - MYELODYSPLASIA-RELATED CYTOGENETIC ABNORMALITES IN CHILDHOOD ACUTE MYELOID LEUKEMIA – A 20-YEAR I-BFM- AML COLLABORATIVE DATABASE STUDY
38. P6 - NPM1 MUTATIONS IN CHILDREN WITH MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS
39. OC 20 - GENOTYPE/PHENOTYPE ASSOCIATIONS IN 174 INDIVIDUALS WITH GERMLINE GATA2 MUTATIONS
40. OC 15 - WHAT CAN WE DEDUCE FROM MOLECULAR CLASSIFICATION OF MYELOID NEOPLASIA FOR THERAPY IN PEDIATRICS?
41. Comprehensive molecular and clinical characterization of NUP98 fusions in pediatric acute myeloid leukemia
42. Genetic variations in low‐to‐medium‐affinity Fcγ receptors and autoimmune neutropenia in early childhood in a Danish cohort
43. Growth hormone deficiency in adult survivors of childhood brain tumors treated with radiation
44. Characteristics and outcome of primary resistant disease in paediatric acute myeloid leukaemia
45. Inflammatory Biomarkers Can Differentiate Acute Lymphoblastic Leukemia with Arthropathy from Juvenile Idiopathic Arthritis Better Than Standard Blood Tests
46. Hypodiploidy has unfavorable impact on survival in pediatric acute myeloid leukemia : An I-BFM Study Group collaboration
47. Measurable residual disease and fusion partner independently predict survival and relapse risk in childhood KMT2A-rearranged acute myeloid leukemia : a study by the international Berlin-Frankfurt-Münster study group
48. Gastrointestinal barrier integrity and mucosal inflammation as risk factors of blood stream infections in children treated for acute lymphoblastic leukaemia
49. The effect of a single SMARCA4 exon deletion on RNA splicing:Implications for variant classification
50. Comprehensive molecular and clinical characterization of NUP98 fusions in pediatric acute myeloid leukemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.